Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in American journal of veterinary research in 2026 evaluated short-term effect of sedation on kidney function markers in cats with chronic kidney disease..
Key Findings
To determine the short-term effect of sedation on GFR markers in cats with chronic kidney disease (CKD). This was a prospective observational study involving client-owned cats with CKD undergoing abdominal sonography. Each cat received 50 mg oral gabapentin, 0.3 mg/kg butorphanol, and 0.3 mg/kg midazolam IM followed by 1 mg/kg alfaxalone IV to effect. Presedation blood tests included hematology and biochemistry. A second blood test for GFR markers (symmetric dimethylarginine [SDMA] and creatinine) was collected at the point of maximum sedation (20 cats) or 2 hours after sedation (12 cats). 20 cats had presedation SDMA and creatinine...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
List
Add
Please enter a comment